{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:51:56Z","timestamp":1790146316180,"version":"4.0.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:00:00Z","timestamp":1549065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009139","name":"German Center for Infection Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"the Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["EXC 22167-390884018"],"award-info":[{"award-number":["EXC 22167-390884018"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Two new drugs, delamanid and bedaquiline, have recently been approved for treatment of multidrug-resistant and extensively drug-resistant (XDR) tuberculosis. Here, we report a case of clofazimine, bedaquiline, and low-level delamanid resistances acquired during treatment of a patient with XDR tuberculosis.<\/jats:p>","DOI":"10.1093\/cid\/ciz074","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T15:16:30Z","timestamp":1548083790000},"page":"1229-1231","source":"Crossref","is-referenced-by-count":65,"title":["Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment"],"prefix":"10.1093","volume":"69","author":[{"given":"Silke","family":"Polsfuss","sequence":"first","affiliation":[{"name":"Institute for Microbiology, Immunology and Laboratory Medicine, Helios Klinikum Emil von Behring, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Hofmann-Thiel","sequence":"additional","affiliation":[{"name":"Synlab Gauting, synlab MVZ Humane Genetik"},{"name":"IML red GmbH, Tuberculosis Supranational Reference Laboratory, Gauting"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Merker","sequence":"additional","affiliation":[{"name":"Molecular and Experimental Mycobacteriology, Research Center Borstel"},{"name":"German Center for Infection Research, Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Borstel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Krieger","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Niemann","sequence":"additional","affiliation":[{"name":"Molecular and Experimental Mycobacteriology, Research Center Borstel"},{"name":"German Center for Infection Research, Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Borstel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"R\u00fcssmann","sequence":"additional","affiliation":[{"name":"Institute for Microbiology, Immunology and Laboratory Medicine, Helios Klinikum Emil von Behring, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sch\u00f6nfeld","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Synlab Gauting, synlab MVZ Humane Genetik"},{"name":"IML red GmbH, Tuberculosis Supranational Reference Laboratory, Gauting"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kranzer","sequence":"additional","affiliation":[{"name":"National Reference Laboratory for Mycobacteria, Research Center Borstel, Borstel, Germany"},{"name":"Clinical Research Unit, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,2]]},"reference":[{"key":"2019091313014940300_CIT0001","volume-title":"Global tuberculosis report 2017","year":"2017"},{"key":"2019091313014940300_CIT0002","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","volume":"15","author":"Dheda","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2019091313014940300_CIT0003","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"N Engl J Med"},{"key":"2019091313014940300_CIT0004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1164\/rccm.201502-0372LE","article-title":"Delamanid and bedaquiline resistance in Mycobacterium tuberculosis ancestral Beijing genotype causing extensively drug-resistant tuberculosis in a Tibetan refugee","volume":"193","author":"Hoffmann","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2019091313014940300_CIT0005"},{"key":"2019091313014940300_CIT0006","volume-title":"Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis","year":"2018"},{"key":"2019091313014940300_CIT0007","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/JCM.02741-12","article-title":"Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations","volume":"51","author":"Rigouts","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2019091313014940300_CIT0008","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/jac\/dkw044","article-title":"Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC\u2122 MGIT\u2122 960 system","volume":"71","author":"Schena","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2019091313014940300_CIT0009"},{"key":"2019091313014940300_CIT0010","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1371\/journal.pmed.0030466","article-title":"OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice","volume":"3","author":"Matsumoto","year":"2006","journal-title":"PLoS Med"},{"key":"2019091313014940300_CIT0011","doi-asserted-by":"crossref","first-page":"e102135","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of Mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PLoS One"},{"key":"2019091313014940300_CIT0012","first-page":"684","article-title":"Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline","volume":"72","author":"Villellas","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2019091313014940300_CIT0013","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1473-3099(18)30100-2","article-title":"Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study","volume":"18","author":"Ferlazzo","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/7\/1229\/30002833\/ciz074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T03:48:44Z","timestamp":1568951324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/7\/1229\/5305974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,2]]},"references-count":13,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,2,2]]},"published-print":{"date-parts":[[2019,9,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz074","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10,1]]},"published":{"date-parts":[[2019,2,2]]}}}